Is a longevity clinic worth it in 2026? The honest answer is that it depends on one question, whether the clinic treats as well as it measures. The market splits into two different products wearing one label. Diagnostics-first longevity programs sell an expensive annual assessment and hand you a report. Clinician-led programs measure and then prescribe and titrate treatment over time. One of those changes biomarkers. The other changes nothing until you find a clinician to act on the report and you pay for that clinician again elsewhere.
- Diagnostics-only longevity programs sell measurement without treatment.
- Clinician-led programs treat what the measurements find, which is where value lives.
- Fountain Life APEX runs roughly $19,500 to $23,500 a year, Human Longevity about $8,000, Function Health $365, hedged as commonly reported.
- None of the diagnostics-only tiers include ongoing prescribing and that is the structural gap.
- GoodLife Health's $299 flat fee covers the clinician, four Biomarker Audits a year and zero markup on any prescription.
The two products inside one label
The longevity clinic label covers a wide price ladder and the ladder hides a product boundary. At the top sit the diagnostics-first programs. Fountain Life APEX is commonly reported at roughly $19,500 to $23,500 a year and Human Longevity's executive assessment is commonly reported at about $8,000 a year. These are assessments. MRI, whole-body imaging, deep panels and a long report. What they do not include is ongoing prescribing. If the report finds an elevated ApoB, the treatment happens somewhere else, with someone else, billed separately.
Function Health is commonly reported at $365 a year and it is the same product at a different price point. Broad labs, a dashboard and no physician relationship. You receive a PDF and a biological age and the clinical work happens nowhere.
At the other end of the label sits the clinician-led model. A membership that includes the panel, the clinician who reads it and the prescriptive authority to act on it, quarter after quarter. That is a different product and the price ladder rarely makes the boundary visible.
A report is not a treatment. The value of a longevity program is not the scan, it is whether the same relationship that reads the scan can prescribe and titrate what the scan finds.
The cost math of the label, honestly
Here is the annual arithmetic of the diagnostics-only tier, using commonly reported figures hedged as such.
| Program | Commonly reported price | What it includes | What it excludes |
|---|---|---|---|
| Fountain Life APEX | ~$19,500 to $23,500/yr | Deep diagnostics, imaging, long report | Ongoing prescribing, treatment relationship |
| Human Longevity Executive Health | ~$8,000/yr | Assessment, genome, report | Ongoing prescribing, treatment relationship |
| Function Health | ~$365/yr | Broad labs, dashboard | Clinician relationship, treatment |
| GoodLife Health | $299/mo ($598 held at sign-up, charged only if accepted) | Clinician, 4 Biomarker Audits/yr, protocol | Medication, billed by the pharmacy at its own price |
The honest comparison is not price for price. It is what happens after the abnormal result. In the diagnostics-only model, the abnormal ApoB or the rising HbA1c produces a recommendation to see someone. In the clinician-led model, the same abnormal result produces a protocol change inside the same relationship, at the next quarterly audit.
What the evidence says longevity programs can and cannot do
The biomarkers that actually predict cardiovascular and metabolic outcomes are well established. Apolipoprotein B (ApoB), Lipoprotein (A), Hemoglobin A1c (HbA1c), Fasting Insulin and Hs-CRP carry real prognostic weight and the evidence for acting on them is strong. Where the longevity industry overreaches is in the layers sold above that foundation, whole-body MRI screening in asymptomatic people, exotic epigenetic age clocks and supplement stacks. The USPSTF does not recommend whole-body MRI for asymptomatic adults and the evidence for intervention on the exotic tier is thin enough that serious clinicians hedge.
The honest position is that the foundational tier is where the leverage is. Measure the core biomarkers four times a year, act on what they show with evidence-based treatment and treat the exotic tier as an optional expense for people who want it, not a need.
What a clinician-led membership looks like
The Cardiometabolic Optimization Membership is one flat $299 per month. It covers the clinical relationship, four Biomarker Audits a year through Quest Diagnostics and the protocol work that follows from them. It starts with $598 held on your card at sign-up, covering the first two months. The hold is charged only once the clinician accepts you and if you are not accepted it is released and you are never charged. Once accepted, the first two months are non-refundable. From month three it is month to month.
Medication is the second charge and it is always separate. Any prescription, branded GLP-1, hormone therapy or thyroid support, is written to your pharmacy and billed at pharmacy cost with zero markup on our side. There is no molecule upcharge and no dose upcharge, ever. The fee never rises with the dose, so the titration follows the medicine rather than the revenue.
Who each model serves
The diagnostics-only tier serves a specific person well. If you want a deep annual look and you already have a trusted clinician who will act on the report, the assessment has value. If you are the kind of buyer who wants the exotic tier, the imaging and the biological age and you accept that the report is not a treatment, that is a legitimate consumer choice.
The clinician-led model serves a different need. If the goal is to move biomarkers over time, the same relationship that reads the panel must be able to prescribe. That is the structural gap in the diagnostics-only tier and the reason the comparison is about treatment, not price.
Frequently Asked Questions
Is a longevity clinic worth it in 2026?
It depends on whether the program treats as well as it measures. Diagnostics-only programs sell an expensive assessment and a report with no ongoing prescribing. Clinician-led programs measure and treat inside one relationship. The value question is whether the same relationship can act on what the panel finds.
What does Fountain Life APEX cost?
Commonly reported at roughly $19,500 to $23,500 a year for the APEX program, diagnostics only, no ongoing prescribing. Prices change.
Is Function Health a longevity clinic?
It is a testing service rather than a clinic. Commonly reported at $365 a year, it provides broad labs and a dashboard with no clinician relationship or treatment.
Does GoodLife Health include imaging like whole-body MRI?
The Biomarker Audit is a blood panel, not imaging. The foundational biomarkers, Apolipoprotein B (ApoB), Lipoprotein (A), Hs-CRP, Hemoglobin A1c (HbA1c), Fasting Insulin and TSH With Reflex To Free T4, carry the prognostic weight that changes outcomes and we do not sell exotic imaging.
Does the membership cover medication?
No. The fee covers the clinician and four Biomarker Audits a year. Medication is billed by your pharmacy separately at pharmacy cost with zero markup on our side.
Can I use HSA or FSA funds?
We do not promise eligibility. Your account administrator decides, so check with them before using those funds. The same caution applies to the medication, which is a separate pharmacy charge.
How fast can I start?
The eligibility check takes a few minutes and a clinician reviews every application. If accepted, the first draw can be booked within days and results return in 9 to 13 days. You are never charged unless you are accepted into care.
One last thing
The question underneath is what you want the money to do. If it should buy measurement alone, the market has a wide ladder for that. If it should buy measurement and the clinical authority to act on it, the relationship has to include prescribing. Ask any program you evaluate one question. When the panel comes back abnormal, who changes the protocol and when?
Related Guides
- Cardiometabolic Optimization: the definitive guide
- What a Biomarker Audit includes
- Direct primary care explained
- Is a functional medicine doctor the same as a concierge doctor?
References
- US Preventive Services Task Force, screening recommendations overview. uspreventiveservicestaskforce.org
- Arnett DK et al. 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease, Circulation, 2019. doi.org/10.1161/CIR.0000000000000678
- Concierge medicine fee ranges and enrollment patterns, commonly reported. en.wikipedia.org/wiki/Concierge_medicine